Industry: Pharmaceuticals, Biotechnology
Fulcrum SP itself is a biotech company in operation since 2001. To date, approximately $1.6M have been applied by Fulcrum to the development, refinement and marketing of SP1 systems and applications. Fulcrum currently funds NBP’s work. NBP is seeking equity capital from private investors and VC firms to fund the anti-cancer program. ( www.fulcrumsp.com )
Fulcrum SP Ltd
Wood End Lane
Fradley, Staffordshire WS13 8NF
United Kingdom
Tel: +44 1543 414704
Fax: +44 1543 255666